AWS
TCRT icon

Atria Wealth Solutions’s Alaunos Therapeutics TCRT Stock Holding History

Atria Wealth Solutions’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,115
Closed -$7.79K – 2044
2024
Q2 		$7.79K Hold
1,115
– – ﹤0.01% 1914
2024
Q1 		$20.2K Buy
1,115
+210
+23% +$4.2K ﹤0.01% 1942
2023
Q4 		$9.59K Buy
905
+604
+201% +$7.27K ﹤0.01% 1916
2023
Q3 		$5.96K Hold
301
– – ﹤0.01% 1855
2023
Q2 		$23.1K Buy
301
+33
+12% +$2.67K ﹤0.01% 1841
2023
Q1 		$25.3K Hold
268
– – ﹤0.01% 1834
2022
Q4 		$26.1K Hold
268
– – ﹤0.01% 1773
2022
Q3 		$69.1K Hold
268
– – ﹤0.01% 1672
2022
Q2 		$50K Buy
+268
New +$25.6K ﹤0.01% 1581

Other funds holding TCRT

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
SWM
Sugarloaf Wealth Management Duluth, Georgia $529M AUM 14.14% 1-Year Est. Return

Atria Wealth Solutions's TCRT Position: Q3 2024 in Review

Atria Wealth Solutions sold out of Alaunos Therapeutics (TCRT) in Q3 2024, closing a stake of 1,115 shares — an estimated $7.79K sold.

Atria Wealth Solutions first reported a position in TCRT in Q2 2022 and held it in 9 quarters. The position peaked at $69.1K in Q3 2022. 29 funds tracked by Wall St. Rank hold TCRT as of Q3 2024.

  • Atria Wealth Solutions reported no remaining Alaunos Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Atria Wealth Solutions sold 1,115 Alaunos Therapeutics shares in Q3 2024, an estimated $7.79K.
  • Atria Wealth Solutions first reported a position in Alaunos Therapeutics in Q2 2022 and held it in 9 quarters.
  • Atria Wealth Solutions's Alaunos Therapeutics position peaked at $69.1K in Q3 2022.
  • 29 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2024.

Based on Atria Wealth Solutions's 13F filing for Q3 2024, filed 8 Nov 2024.